SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Federico Pea, Piergiorgio Cojutti, Lucia Dose, Massimo Baraldo, A 1 year retrospective audit of quality indicators of clinical pharmacological advice for personalized linezolid dosing: one stone for two birds?, British Journal of Clinical Pharmacology, 2016, 81, 2
  2. 2
    Abdulaziz S. Alobaid, Maya Hites, Jeffrey Lipman, Fabio Silvio Taccone, Jason A. Roberts, Effect of obesity on the pharmacokinetics of antimicrobials in critically ill patients: A structured review, International Journal of Antimicrobial Agents, 2016, 47, 4, 259

    CrossRef

  3. 3
    Raül Rigo-Bonnin, Sara Cobo-Sacristán, Ariadna Padullés, Alba Ribera, Ariadna Arbiol-Roca, Óscar Murillo, Joan Sabater-Riera, Pedro Alía, Measurement of ceftazidime concentration in human plasma by ultra-performance liquid chromatography–tandem mass spectrometry. Application to critically ill patients and patients with osteoarticular infections, Biomedical Chromatography, 2016, 30, 3
  4. 4
    Jason A. Roberts, Gordon Y. S. Choi, Gavin M. Joynt, Sanjoy K. Paul, Renae Deans, Sandra Peake, Louise Cole, Dianne Stephens, Rinaldo Bellomo, John Turnidge, Steven C. Wallis, Michael S. Roberts, Darren M. Roberts, Melissa Lassig-Smith, Therese Starr, Jeffrey Lipman, SaMpling Antibiotics in Renal Replacement Therapy (SMARRT): an observational pharmacokinetic study in critically ill patients, BMC Infectious Diseases, 2016, 16, 1

    CrossRef

  5. 5
    K. de With, F. Allerberger, S. Amann, P. Apfalter, H.-R. Brodt, T. Eckmanns, M. Fellhauer, H. K. Geiss, O. Janata, R. Krause, S. Lemmen, E. Meyer, H. Mittermayer, U. Porsche, E. Presterl, S. Reuter, B. Sinha, R. Strauß, A. Wechsler-Fördös, C. Wenisch, W. V. Kern, Strategies to enhance rational use of antibiotics in hospital: a guideline by the German Society for Infectious Diseases, Infection, 2016,

    CrossRef

  6. 6
    Kerina J. Denny, Menino O. Cotta, Suzanne L. Parker, Jason A. Roberts, Jeffrey Lipman, The use and risks of antibiotics in critically ill patients, Expert Opinion on Drug Safety, 2016, 1

    CrossRef

  7. 7
    Sophie Paviour, Stefanie Hennig, Christine E. Staatz, Usage and monitoring of intravenous tobramycin in cystic fibrosis in Australia and the UK, Journal of Pharmacy Practice and Research, 2016, 46, 1
  8. 8
    Abdulaziz S. Alobaid, Alexander Brinkmann, Otto R. Frey, Anka C. Roehr, Sonia Luque, Santiago Grau, Gloria Wong, Mohd-Hafiz Abdul-Aziz, Michael S. Roberts, Jeffrey Lipman, Jason A. Roberts, What is the effect of obesity on piperacillin and meropenem trough concentrations in critically ill patients?, Journal of Antimicrobial Chemotherapy, 2016, 71, 3, 696

    CrossRef

  9. 9
    Breanna L. Carter, Kendra M. Damer, Todd A. Walroth, Natalie R. Buening, David R. Foster, Rajiv Sood, A Systematic Review of Vancomycin Dosing and Monitoring in Burn Patients, Journal of Burn Care & Research, 2015, 36, 6, 641

    CrossRef

  10. 10
    Abdel Chahbouni, Frank AM van den Dungen, René M Vos, Jeroen CG den Burger, Amo Sinjewel, Abraham J Wilhelm, Agnes I Veldkamp, Eleanor L Swart, Mirjam M van Weissenbruch, An UPLC–MS detection method for the quantification of five antibiotics in human plasma, Bioanalysis, 2015, 7, 18, 2321

    CrossRef

  11. 11
    Adrian Losoya-Leal, M.-Carmen Estevez, Sergio O. Martínez-Chapa, Laura M. Lechuga, Design of a surface plasmon resonance immunoassay for therapeutic drug monitoring of amikacin, Talanta, 2015, 141, 253

    CrossRef

  12. 12
    Roger L Nation, Jian Li, Otto Cars, William Couet, Michael N Dudley, Keith S Kaye, Johan W Mouton, David L Paterson, Vincent H Tam, Ursula Theuretzbacher, Brian T Tsuji, John D Turnidge, Framework for optimisation of the clinical use of colistin and polymyxin B: the Prato polymyxin consensus, The Lancet Infectious Diseases, 2015, 15, 2, 225

    CrossRef

  13. 13
    M. Hites, F. S. Taccone, Optimization of antibiotic therapy in the obese, critically ill patient, Réanimation, 2015, 24, 3, 278

    CrossRef

  14. 14
    Cédric Bretonnière, Stratégies de réduction de l’utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique), Anesthésie & Réanimation, 2015, 1, 4, 373

    CrossRef

  15. 15
    G. Wong, A. Brinkman, R. J. Benefield, M. Carlier, J. J. De Waele, N. El Helali, O. Frey, S. Harbarth, A. Huttner, B. McWhinney, B. Misset, F. Pea, J. Preisenberger, M. S. Roberts, T. A. Robertson, A. Roehr, F. B. Sime, F. S. Taccone, J. P. J. Ungerer, J. Lipman, J. A. Roberts, An international, multicentre survey of  -lactam antibiotic therapeutic drug monitoring practice in intensive care units, Journal of Antimicrobial Chemotherapy, 2014, 69, 5, 1416

    CrossRef

  16. 16
    Menino Osbert Cotta, Jason A Roberts, Alexis Tabah, Jeffrey Lipman, Dirk Vogelaers, Stijn Blot, Antimicrobial stewardship of β-lactams in intensive care units, Expert Review of Anti-infective Therapy, 2014, 12, 5, 581

    CrossRef

  17. 17
    Marta Ulldemolins, Sergi Vaquer, Mireia Llauradó-Serra, Caridad Pontes, Gonzalo Calvo, Dolors Soy, Ignacio Martín-Loeches, Beta-lactam dosing in critically ill patients with septic shock and continuous renal replacement therapy, Critical Care, 2014, 18, 3, 227

    CrossRef

  18. 18
    M.G. Vossen, J.T. Kielstein, F. Thalhammer, Dosierung von Antiinfektiva bei CKD (5D), Der Nephrologe, 2014, 9, 6, 452

    CrossRef

  19. 19
    Federico Pea, Lucia Dose, Piergiorgio Cojutti, Massimo Baraldo, Fabrizio Fontana, Carlo Favaretti, Mario Furlanut, Educational and Organizational Interventions to Improve the Usefulness of Clinical Pharmacological Advice for Personalized Drug Dosing Based on Therapeutic Drug Monitoring, Basic & Clinical Pharmacology & Toxicology, 2014, 115, 5
  20. 20
    Jason A Roberts, Mohd H Abdul-Aziz, Jeffrey Lipman, Johan W Mouton, Alexander A Vinks, Timothy W Felton, William W Hope, Andras Farkas, Michael N Neely, Jerome J Schentag, George Drusano, Otto R Frey, Ursula Theuretzbacher, Joseph L Kuti, Individualised antibiotic dosing for patients who are critically ill: challenges and potential solutions, The Lancet Infectious Diseases, 2014, 14, 6, 498

    CrossRef

  21. 21
    Xinghai Ning, Wonewoo Seo, Seungjun Lee, Kiyoko Takemiya, Mohammad Rafi, Xuli Feng, Daiana Weiss, Xiaojian Wang, Larry Williams, Vernon M. Camp, Malveaux Eugene, W. Robert Taylor, Mark Goodman, Niren Murthy, PET Imaging of Bacterial Infections with Fluorine-18-Labeled Maltohexaose, Angewandte Chemie, 2014, 126, 51
  22. 22
    Xinghai Ning, Wonewoo Seo, Seungjun Lee, Kiyoko Takemiya, Mohammad Rafi, Xuli Feng, Daiana Weiss, Xiaojian Wang, Larry Williams, Vernon M. Camp, Malveaux Eugene, W. Robert Taylor, Mark Goodman, Niren Murthy, PET Imaging of Bacterial Infections with Fluorine-18-Labeled Maltohexaose, Angewandte Chemie International Edition, 2014, 53, 51
  23. 23
    Fekade Bruck Sime, Michael S. Roberts, Jason A. Roberts, Thomas A. Robertson, Simultaneous determination of seven β-lactam antibiotics in human plasma for therapeutic drug monitoring and pharmacokinetic studies, Journal of Chromatography B, 2014, 960, 134

    CrossRef

  24. 24
    Jean-Pierre Bédos, Bernard Allaouchiche, Laurence Armand-Lefèvre, Olivier Baldesi, Lila Bouadma, Dominique Decré, Samy Figueiredo, Rémy Gauzit, Benoit Guery, Nicolas Joram, Boris Jung, Sigismond Lasocki, Alain Lepape, Fabrice Lesage, Olivier Pajot, François Philippart, Bertrand Souweine, Pierre Tattevin, Jean-François Timsit, Jean-Ralph Zahar, Cédric Bretonnière, Marc Leone, Christophe Milési, Benoît Misset, Stratégies de réduction de l’utilisation des antibiotiques à visée curative en réanimation (adulte et pédiatrique), Réanimation, 2014, 23, 5, 558

    CrossRef

  25. 25
    Jan J. De Waele, S. Carrette, M. Carlier, V. Stove, J. Boelens, G. Claeys, I. Leroux-Roels, E. Hoste, P. Depuydt, J. Decruyenaere, A. G. Verstraete, Therapeutic drug monitoring-based dose optimisation of piperacillin and meropenem: a randomised controlled trial, Intensive Care Medicine, 2014, 40, 3, 380

    CrossRef

  26. 26
    J.A. Roberts, V. Stove, J.J. De Waele, B. Sipinkoski, B. McWhinney, J.P.J. Ungerer, M. Akova, M. Bassetti, G. Dimopoulos, K.-M. Kaukonen, D. Koulenti, C. Martin, P. Montravers, J. Rello, A. Rhodes, T. Starr, S.C. Wallis, J. Lipman, Variability in protein binding of teicoplanin and achievement of therapeutic drug monitoring targets in critically ill patients: Lessons from the DALI Study, International Journal of Antimicrobial Agents, 2014, 43, 5, 423

    CrossRef

  27. 27
    Dagan O. Lonsdale, Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman, Antibacterial therapeutic drug monitoring in cerebrospinal fluid: difficulty in achieving adequate drug concentrations, Journal of Neurosurgery, 2013, 118, 2, 297

    CrossRef

  28. 28
    Andrew A. Udy, Jason A. Roberts, Jeffrey Lipman, Clinical implications of antibiotic pharmacokinetic principles in the critically ill, Intensive Care Medicine, 2013, 39, 12, 2070

    CrossRef

  29. 29
    Jason A. Roberts, Jeffrey Lipman, Optimal Doripenem Dosing Simulations in Critically Ill Nosocomial Pneumonia Patients With Obesity, Augmented Renal Clearance, and Decreased Bacterial Susceptibility*, Critical Care Medicine, 2013, 41, 2, 489

    CrossRef

  30. 30
    R. Daghrir, P. Drogui, Tetracycline antibiotics in the environment: a review, Environmental Chemistry Letters, 2013, 11, 3, 209

    CrossRef

  31. 31
    Yoshiro Hayashi, Jeffrey Lipman, Andrew A. Udy, Mandy Ng, Brett McWhinney, Jacobus Ungerer, Karin Lust, Jason A. Roberts, β-Lactam therapeutic drug monitoring in the critically ill: optimising drug exposure in patients with fluctuating renal function and hypoalbuminaemia, International Journal of Antimicrobial Agents, 2013, 41, 2, 162

    CrossRef

  32. 32
    Philip A. Routledge, Alun D. Hutchings, The Immunoassay Handbook, 2013,

    CrossRef

  33. 33
    Scott E. Briscoe, Brett C. McWhinney, Jeffrey Lipman, Jason A. Roberts, Jacobus P.J. Ungerer, A method for determining the free (unbound) concentration of ten beta-lactam antibiotics in human plasma using high performance liquid chromatography with ultraviolet detection, Journal of Chromatography B, 2012, 907, 178

    CrossRef

  34. 34
    Jason A Roberts, Jan J De Waele, George Dimopoulos, Despoina Koulenti, Claude Martin, Philippe Montravers, Jordi Rello, Andrew Rhodes, Therese Starr, Steven C Wallis, Jeffrey Lipman, DALI: Defining Antibiotic Levels in Intensive care unit patients: a multi-centre point of prevalence study to determine whether contemporary antibiotic dosing for critically ill patients is therapeutic, BMC Infectious Diseases, 2012, 12, 1, 152

    CrossRef

  35. 35
    Fekade Sime, Michael S Roberts, Sandra L Peake, Jeffrey Lipman, Jason A Roberts, Does Beta-lactam Pharmacokinetic Variability in Critically Ill Patients Justify Therapeutic Drug Monitoring? A Systematic Review, Annals of Intensive Care, 2012, 2, 1, 35

    CrossRef

  36. 36
    Flint Russett, Hospital Pharmacy Pulse - Recent Publications on Medications and Pharmacy, Hospital Pharmacy, 2012, 47, 2, 156

    CrossRef

  37. 37
    Mieke Carlier, Veronique Stove, Jason A. Roberts, Eric Van de Velde, Jan J. De Waele, Alain G. Verstraete, Quantification of seven β-lactam antibiotics and two β-lactamase inhibitors in human plasma using a validated UPLC-MS/MS method, International Journal of Antimicrobial Agents, 2012, 40, 5, 416

    CrossRef

  38. 38
    M. Göböová, M. Kuželová, T. Foltánová, The problem of low peak concentration of gentamicin in clinical practice, Acta Facultatis Pharmaceuticae Universitatis Comenianae, 2012, 59, Supplement VI

    CrossRef

  39. 39
    Andrew A. Udy, Jason A. Roberts, Jan J. De Waele, David L. Paterson, Jeffrey Lipman, What's behind the failure of emerging antibiotics in the critically ill? Understanding the impact of altered pharmacokinetics and augmented renal clearance, International Journal of Antimicrobial Agents, 2012, 39, 6, 455

    CrossRef

  40. 40
    Mahipal G Sinnollareddy, Michael S Roberts, Jeffrey Lipman, Jason A Roberts, β-Lactam pharmacokinetics and pharmacodynamics in critically ill patients and strategies for dose optimization: A structured review, Clinical and Experimental Pharmacology and Physiology, 2012, 39, 6
  41. 41
    Sources of Erroneous Results in Therapeutic Drug Monitoring Due to Preanalytical Errors, High Bilirubin, Hemolysis, and Lipids,